PCN89 Cost Effectiveness of Treatment With New 6-Month Leuprorelin Acetate Formulation in Patients With Advanced Prostate Cancer
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2129
https://www.valueinhealthjournal.com/article/S1098-3015(12)03843-0/fulltext
Title :
PCN89 Cost Effectiveness of Treatment With New 6-Month Leuprorelin Acetate Formulation in Patients With Advanced Prostate Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03843-0&doi=10.1016/j.jval.2012.08.2129
First page :
A425
Section Title :
Cancer
Open access? :
No
Section Order :
782